Potassium Carbonate → 7-(4-ethoxyphenyl)-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]2,3-dihydro-1-benzoazepine-4-carboxamide

HRID 566057ノート

反応式

HRID 566057 の反応式
B([O-])([O-])O[C:3]1[CH:8]=[CH:7][C:6]([O:9][CH2:10][CH3:11])=[CH:5][CH:4]=1.Br[C:15]1[CH:16]=[CH:17][C:18]2[N:24]([CH3:25])[CH2:23][CH2:22][C:21]([C:26]([NH:28][C:29]3[CH:34]=[CH:33][C:32]([CH2:35][N:36]([CH3:43])[CH:37]4[CH2:42][CH2:41][O:40][CH2:39][CH2:38]4)=[CH:31][CH:30]=3)=[O:27])=[CH:20][C:19]=2[CH:44]=1.C(=O)([O-])[O-].[K+].[K+]>O.C(O)C.C1(C)C=CC=CC=1.C(OCC)(=O)C>[CH2:10]([O:9][C:6]1[CH:7]=[CH:8][C:3]([C:15]2[CH:16]=[CH:17][C:18]3[N:24]([CH3:25])[CH2:23][CH2:22][C:21]([C:26]([NH:28][C:29]4[CH:30]=[CH:31][C:32]([CH2:35][N:36]([CH3:43])[CH:37]5[CH2:42][CH2:41][O:40][CH2:39][CH2:38]5)=[CH:33][CH:34]=4)=[O:27])=[CH:20][C:19]=3[CH:44]=2)=[CH:4][CH:5]=1)[CH3:11]

参加物

6

反応物 3

HCID 11430Potassium CarbonateHCID 223290367-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamideHCID 86756168HCID 86756168、化合物

生成物 1

HCID 184725957-(4-ethoxyphenyl)-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]2,3-dihydro-1-benzoazepine-4-carboxamide収率 35%

試薬・触媒・溶媒 2

HCID 8857Ethyl Acetate溶媒HCID 86587398Ethanol toluene water溶媒

実験手順

In water:ethanol:toluene (1:1:10, 18.0 ml) were dissolved 4-ethoxyphenyl borate (252 mg) and 7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide (613 mg), and to the mixture was added potassium carbonate (420 mg). The mixture was stirred under argon atmosphere for 30 minutes, and to the mixture was added tetrakistriphenylphosphine palladium (59 mg). Under argon atmosphere, the mixture was refluxed for 17 hours. The mixture was diluted with ethyl acetate (200 ml) and washed with water (50 ml) and saturated brine (50 ml). The organic layer was dried with anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified with silica gel column chromatography (75 g, ethyl acetate:ethanol=9:1) and recrystallized from ethanol to give 7-(4-ethoxyphenyl)-1-methyl-N-[4-[[N-methyl-N-(tetrahydropyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1-benzoazepine-4-carboxamide (Compound 306) (230 mg, 35%).

後処理

  1. temperatureUnder argon atmosphere, the mixture was refluxed for 17 hours
  2. washwashed with water (50 ml) and saturated brine (50 ml)
  3. dry with materialThe organic layer was dried with anhydrous magnesium sulfate
  4. customthe solvent was evaporated under reduced pressure
  5. customThe residue was purified with silica gel column chromatography (75 g, ethyl acetate:ethanol=9:1)
  6. customrecrystallized from ethanol

出典と根拠

ORDレコード
ord-35d25b4971f34748bfae76db7ec8714f
出典データセット
uspto-grants-2001_01
特許番号
US06172061B2

反応ノート

読み込み中…